![]() |
Volumn 83, Issue 1, 2015, Pages 53-55
|
Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis
|
Author keywords
Antibiotic; Beta lactam; Cystic fibrosis; Pseudomonas; Susceptibility
|
Indexed keywords
CEFTAZIDIME;
CEFTOLOZANE PLUS TAZOBACTAM;
MEROPENEM;
PIPERACILLIN PLUS TAZOBACTAM;
ANTIINFECTIVE AGENT;
BETA LACTAM;
ADOLESCENT;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC SENSITIVITY;
ARTICLE;
BACTERIUM ISOLATION;
BROTH DILUTION;
CLINICAL ARTICLE;
CYSTIC FIBROSIS;
HUMAN;
MIC50;
MIC90;
NONHUMAN;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTION;
QUALITY CONTROL;
CHILD;
COMPLICATION;
DRUG EFFECTS;
FEMALE;
ISOLATION AND PURIFICATION;
MALE;
MICROBIAL SENSITIVITY TEST;
MICROBIOLOGY;
ADOLESCENT;
ANTI-BACTERIAL AGENTS;
BETA-LACTAMS;
CHILD;
CYSTIC FIBROSIS;
FEMALE;
HUMANS;
MALE;
MICROBIAL SENSITIVITY TESTS;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
|
EID: 84938739520
PISSN: 07328893
EISSN: 18790070
Source Type: Journal
DOI: 10.1016/j.diagmicrobio.2015.04.012 Document Type: Article |
Times cited : (38)
|
References (9)
|